Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-12-31

FDA Approved: CYANOKIT — Supplemental Application (BTG INTERNATIONAL INC.)

View source ↗

Summary

The FDA approved a supplemental application for Cyanokit (hydroxocobalamin) submitted by BTG INTERNATIONAL INC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cyanokit (hydroxocobalamin)

Snippet

SUPPL AP for CYANOKIT (HYDROXOCOBALAMIN)